Anti-VEGF and anti-complement therapies work on distinct mechanisms in age-related macular degeneration, and both may be ...

Paris: Sanofi has received fast track designation from the US Food and Drug Administration (FDA) for SAR446597, a one-time intravitreal gene therapy for the treatment of geographic atrophy (GA) ...

Continuous use of eye drops in patients with neovascular AMD who receive frequent eye injections soothes dry eye more ...

IRX-101, a new antiseptic tested in patients receiving eye injections for macular degeneration, resulted in less pain and ...

Intravitreal ceftazidime may help treat syphilitic uveitis when IV penicillin is delayed. A case series reported that 14 eyes ...

The development of drug delivery platforms that offer sustained release of therapeutic agents in the retina represents a ...

A case report published in BMC Ophthalmology has highlighted an extremely rare complication of botulinum toxin A (BTA) ...

Intravitreal t-PA was valuable for submacular haemorrhage only in eyes with relatively old haemorrhage. For eyes with recent onset of haemorrhage, t-PA is suggested only if initial gas injection ...

Dexamethasone intravitreal implant is likely to be clinically effective in people with phakic diabetic macular oedema for whom non-corticosteroids are unsuitable 3.7 The company had not provided any ...

In a separate study, an implant containing a different investigational endothelin antagonist (PER-001) reduced macular ...

“Although intravitreal anti-VEGF injections have proven to be extremely efficacious for our patients with AMD, RVO-related macular edema, diabetic macular edema and a host of additional ...